The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
Josephine Lampe(German Centre for Cardiovascular Research), Markus Schwaninger(University of Lübeck), Helge Müller‐Fielitz(University of Lübeck), Anke Fähnrich(University of Lübeck), Raphael Schuster(University of Lübeck), Marietta Zille(Institute of Pharmacology), Rubén Nogueiras(Universidade de Santiago de Compostela), Hermann C. Altmeppen(Universität Hamburg), Roberto Villaseñor(Roche (Switzerland)), Olaf Jöhren(University of Lübeck), Sonja Binder(University of Lübeck), Rolf Hilgenfeld(German Center for Infection Research), Markus Krohn(German Centre for Cardiovascular Research), Ümit Özorhan(German Centre for Cardiovascular Research), Ludovic Collin(Roche (Switzerland)), Jan Wenzel(University of Lübeck), Markus Glatzel(Universität Hamburg), Manolis Pasparakis(University of Cologne), Vincent Prévot(Inserm), Hauke Busch(German Cancer Research Center), Vanessa Neve(PYC Therapeutics (Australia)), Linlin Zhang(German Center for Infection Research), Fabian Ott(University of Lübeck), K.-M. Müller(Leuphana University of Lüneburg), Yun Jiang(Jiangnan University)
Cited by 18
Related Papers
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Multiorgan and Renal Tropism of SARS-CoV-2
|New England Journal of Medicine|2020|1.9k
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
|The Lancet Neurology|2020|1.4k